FOR PATIENTS AS YOUNG AS 4 YEARS OLD

IT’S YOUR TIME
TO IMAGINE
LESS SICKLING

HAJAR

Student, artist, and actual Oxbryta patient

IT'S YOUR TIME

TO IMAGINE
LESS SICKLING

ARELYS

Mother, traveler, and actual Oxbryta patient

INDICATION: OXBRYTA is a prescription medicine used for the treatment of sickle cell disease in adults and children 4 years of age and older. It is not known if OXBRYTA is safe and effective in children with sickle cell disease below 4 years of age. OXBRYTA is approved under accelerated approval based on an increase in hemoglobin. Continued approval may depend on verification of clinical benefits in ongoing trials.

REAL PEOPLE.

REAL STORIES.

Hajar and her mother and caregiver Mapillar reflect on how sickle cell has impacted Hajar’s life at home and school.

HEAR MORE STORIES
See transcript

CONNECT WITH THE COMMUNITY

Sign up for virtual or local educational events to learn from a specialist about sickle cell and how Oxbryta treats sickling at its source.

ABRAHAM

Actual Oxbryta patient